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Abstract: Background: Most published literature using SELDI-TOF has used traditional techniques in Spectral Analysis 
such as Fourier transforms and wavelets for denoising. Most of these publications also compare spectra using their most 
prominent feature, i.e, peaks or local maximums. Methods: The maximum intensity value within each window of differen-
tiable m/z values was used to represent the intensity level in that window. We also calculated the ‘Area under the Curve’ 
(AUC) spanned by each window. Results: Keeping everything else constant, such as pre-processing of the data and the 
classiﬁ  er used, the AUC performed much better as a metric of comparison than the peaks in two out of three data sets. In 
the third data set both metrics performed equivalently. Conclusions: This study shows that the feature used to compare 
spectra can have an impact on the results of a study attempting to identify biomarkers using SELDI TOF data.
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Introduction
The effort to produce an index of all human proteins (the human protein index, HPI) began over twenty 
years ago. This project pre-dates the human genome project by more than a decade. However, the 
complexity of the task of creating this index was underestimated and the relative simplicity of the human 
genome with four known nucleic acids arranged in a linear coding order allowed the process of the 
sequencing of the human genome to progress exponentially (Anderson et al 2001). The successful 
completion of the human genome project and the limited correlation between gene expression and 
protein expression has shifted the focus of much research back to proteins. The emergence of new 
and improved protein technologies from re-engineered two dimensional (2D) gel systems to Surface 
Enhanced Laser Desorption / Ionization (SELDI) and Matrix Enhanced Laser Desorption and Ionization 
(MALDI) time of ﬂ  ight mass spectroscopy (TOF-MS), are all being used more and more in cancer 
research to aid in the discovery of predictive or prognostic biomarkers. A number of articles in medical 
journals over the last few years suggest that SELDI TOF-MS spectra can be very effective in correctly 
identifying and classifying individuals with cancer from those without (Petricoin et al 2002; Rosty et al 
2002; Shiwa et al 2003; Xiao et al 2003; Wadsworth et al 2004).
SELDI Chip (Ciphergen)
The ProteinChip System uses ProteinChip Arrays and SELDI (surface-enhanced laser desorption /
ionization) technology for capture, detection and analysis of proteins directly from crude biological 
samples without labeling or chemical modiﬁ  cation. Using a combination of arrays displaying unique 
chemical-binding properties (e.g. reverse phase, ion exchange, metal ion), subsets of proteins can be 
afﬁ  nity captured and puriﬁ  ed on the surface of the biochip. The processed arrays containing bound 
proteins are inserted into the ProteinChip reader, a laser-based time-of-ﬂ  ight mass spectrometer for 
rapid analysis of and relative quantiﬁ  cation of hundreds of analytes in parallel. The ProteinChip array 
has eight spots. Small areas on each spot on the ProteinChip can be sampled by the laser and activated 
to emit a spectrum. The height of the spectrum (its y-coordinate) is related to the quantities of proteins 
of a given size (measured in kilo-daltons – x-coordinate). The y-coordinate thus is a measure of the 
amount of proteins (similar to the optical density in a 2-D gel spot), whereas the x-coordinate is a 
constant set of possible values of the molecular weight of the proteins. Each spectrum has between Meleth, Eltoum, Zhu et al
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15000-50000 detectable values. The spectra can 
either be exported after baseline correction and 
normalization or as raw unprocessed data. It is also 
possible to export the spectra with a time scale 
instead of the m/z scale. They are exported as 
comma separated files and stored in an excel 
database.
Analysis of SELDI Spectra
The ultimate aim of a SELDI experiment is to build 
statistical models called classiﬁ  ers to correctly 
classify individuals into the diseased/non-diseased 
categories and then to identify proteins that com-
prise the classiﬁ  er. A SELDI spectrum has a num-
ber of features that can be used to build this 
classiﬁ  er. The feature used most often to compare 
or classify SELDI spectra are the peaks. The 
maximum intensity in a chosen region and the area 
under the curve (AUC) that forms a peak are two 
of multiple features of SELDI spectra that have 
been used. However, the spectra need to be pre-
processed before its features can be used in a clas-
siﬁ  er. Some of the commonly used pre-processing 
techniques are described below.
Normalizing the Spectra
Differential sample loading, differences in surface 
of spots, ﬂ  uctuations in laser energy etc, can con-
tribute to variability in the recorded spectra. “Nor-
malization” is the process of subjecting the 
intensities to arithmetic operations in order to 
minimize the effect of uncontrollable factors on 
the intensity. A common way to do this is to divide 
each intensity value on a spectrum by the total 
intensity of the individual spectrum. This expresses 
each intensity value as a percentage of total inten-
sity, and the percentage of total intensity at each 
m/z value should be the same regardless of factors 
such as sample loading, chip surface etc.
Baseline Subtraction
The process of acquiring the spectra can also con-
tribute to differences in intensities in the different 
spectra due to varying baselines. Baseline subtrac-
tion is a pre-processing step, which essentially tries 
to identify the line (function) that traces the mini-
mum value across the bottom of the spectrum, and 
then subtracts it from the intensities, so that inten-
sities in all spectra are measured from a zero base-
line. Coombes et al 2003 and Baggerly et al 2004 
describe a variety of techniques that can be used 
in baseline subtraction. Ciphergen’s ProteinChip 
software allows one to use their proprietary algo-
rithms to normalize spectra using a variety of 
options and subtract baseline from the spectra 
before exporting it to the database.
Denoising
Denoising is the process of reducing random noise 
in a spectrum to make the signal clearer. Fourier 
transforms (Baggerly et al 2003) and wavelet 
transforms (Lee et al 2003), are some of the 
techniques used to denoise spectra.
Alignment
The machine reading and recording the intensity 
at various m/z values is known to have an error 
rate of approximately 0.2% about its m/z values, 
i.e. if the data says intensity at m/z 2000 is X, X 
could represent the intensity at 1,996 or 2004. The 
spectra from different individuals thus need to be 
adjusted in some way in order to be sure that the 
intensities being compared across different spectra 
represent intensities at the same m/z ratio. Yasui 
et al (2003) describe a method to align spectra. In 
this paper we describe a different method of align-
ing and evaluating spectra.
Feature Selection and Dimension Reduction
After pre-processing the spectra, one has to iden-
tify the subset of spectral features that will be 
used to build a classiﬁ  er. Most publications use 
two sample tests such as t-tests or Wilcoxon rank 
sum tests to identify those features (peaks, 
maximum intensity, or AUCs) that are statistically 
signiﬁ  cantly different between the groups at some 
preset signiﬁ  cance level (e.g. p  0.0001). These 
selected features are then used to build a 
classiﬁ  er.
Classiﬁ  ers
Classiﬁ  ers are algorithms that are used to divide 
a group of individuals into different groups. 
Classifiers that use supervised learning (e.g. 
Discriminant Analysis (Moreno et al 1995; Weber 
et al 2002)) are used in a situation where one 
knows the true groups prior to building the clas-
siﬁ  er. In this case the features of spectra are used 
to construct an algorithm that can divide the 80
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individuals into the correct groups. In unsupervised 
classiﬁ  ers (cluster analysis: Dwek and Alaiya 
2003), the aim is to ﬁ  nd natural clusters of groups 
and then investigate the features of the spectra, to 
understand what they can teach us about the 
groups.
Rationale for this Paper
As mentioned above, Ciphergen’s SELDI machine 
has an error rate of about 0.2% about its m/z 
values. Thus the intensity values +/- 0.2% at each 
m/z values could potentially all represent the total 
intensity at the same m/z ratio. We thus hypoth-
esized that the area under the curve would be a 
better measurement of the intensity of a particu-
lar protein or multiple proteins/peptides in the 
sample than the peak or other measure of local 
maximums such as the maximum intensity in this 
same region. Further we hypothesized that a clas-
siﬁ  er that used AUC would have better sensitivity 
and speciﬁ  city than a classiﬁ  er that used local 
maximums. The paper describes the pre-
processing techniques used and compares the 
quality of these two classiﬁ  ers. To the best of our 
knowledge there are no other studies that have 
compared the effect of feature selection on the 
quality of the classiﬁ  er.
Methods
Pre-processing
Step 1: comparing total ion content: We compared 
the median total protein intensity in the normal 
patients, to the median total intensity in the dis-
eased patients using a Wilcoxon Rank Sum test to 
see if one group of patients is over expressing 
proteins compared to the other.
Step 2: Normalization: Each patient’s intensity 
values were normalized to his/her total intensity. 
This is equivalent to normalization by the total 
ion current. These intensity values were then 
divided by the sum total of intensities in both 
groups. Each intensity value is thus expressed as 
a proportion of the total protein intensity in the 
experiment. This makes fold change comparisons 
meaningful.
Step 3: Alignment and feature selection: As 
described above, the machine reading and record-
ing the intensity at various m/z values is known 
to have an error rate of approximately 0.2% about 
its m/z values, i.e. if the data indicate an intensity 
at m/z 2000 is X, X could represent the intensity 
at 1,996 or 2004 or both. This error rate varies 
increases with increasing m/z values. Each m/z 
value was multiplied by 0.002 to create a variable 
Table 1: Aligning spectra and adjusting for error in measurement. Bolded italicized and underlined values in column 1 indicate the 
beginning of a new window of m/z values that are all represented by the new m/z value in column 2. The new window starts at the m/z 
value at which the cumulative sum of the distances between consecutive m/z values (column 5) is greater that the reliability interval in 
column 3. Column 4 is the distance of each m/z value from its immediately preceding m/z.
M/Z M/Z NEW
Reliability Interval 
= m/z *0.0 02 
(rounded)
Distance from last Cumulative Distance
2000.2475 2003.5541 4 0 0
2001.0739 2003.5541 4 0.8264 0.8264
2001.9004 2003.5541 4 0.8265 1.6529
2002.7272 2003.5541 4 0.8268 2.4797
2003.5541 2003.5541 4 0.8269 3.3066
2004.3811 2007.6911 4 0.827 4.1336 (set to 0)
2005.2084 2007.6911 4 0.8273 1.6547
2006.0358 2007.6911 4 0.8274 2.4823
2007.6911 2007.6911 4 0.8277 3.31
2008.519 2011.8324 4 0.8279 4.1379 (set to 0)
2009.3471 2011.8324 4 0.8281 0.8281
2010.1754 2011.8234 4 0.8283 1.6564
2011.0038 2011.8234 4 0.8284 2.4848
2011.8234 2011.8234 4 0.8286 3.3134
2012.6612 2015.978 4 0.8294 4.1428(set to 0)Meleth, Eltoum, Zhu et al
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that represented the width of its reliability 
interval. The distance between adjacent m/z 
values was calculated by subtracting an m/z value 
from the one immediately after it. We created 
reliability intervals, such that the distance 
between the lowest m/z value in the interval, and 
the highest m/z value in the interval was less than 
or equal to the width of the reliability interval for 
all the m/z values in the interval. All m/z values 
in an interval were then represented by the high-
est m/z value of the interval. Thus, all values 
between 2000 and 2004 were represented by 
2004. Table 1 displays this process for the ﬁ  rst 
twelve values in a spectrum. This process was 
both a process of alignment across the different 
spectra and a process of data reduction. In this 
way approximately 1000 m/z values could repre-
sent the 10000 or more m/z values in the original 
spectra. Two features related to these m/z values 
were used to compare the spectra. The ﬁ  rst of 
these was the maximum intensity value with each 
window, e.g. 2004 represents values from 2000 
to 2004; the largest intensity value within these 
four intensities is used to represent the intensity 
at m/z 2004. The second feature was the area 
under the curve spanned by these four m/z values. 
The area was calculated using a simple trapezoi-
dal rule; the height of the trapezoid, was the 
intensity value halfway between the maximum 
intensity and minimum intensity within this win-
dow. The width of the trapezoid was the differ-
ence between the largest m/z value in the window 
and the lowest.
The Classiﬁ  er
Wilcoxon Rank Sum test was used to compare the 
maximum values and AUCs at each m/z value. 
A subset of the most highly signiﬁ  cantly differen-
tial peaks (AUCs) was subject to Stepwise 
Discriminant Analysis (SWD) that was used to 
select m/z values and intensities to be included in 
the classiﬁ  er. Different cutoffs of p-values were 
used to determine signiﬁ  cance in the Wilcoxon 
Rank sum test for the three different data sets, but 
when both types of classiﬁ  ers were used on the 
same set of data, identical cut-offs were utilized. 
A random sample of diseased and non-diseased 
patients was selected. SWD was run on this random 
sample to identify a subset of the signiﬁ  cant local 
maximums that could classify the patients correctly 
into disease/non-disease groups.
This process was repeated 10,000 times. In 
order to avoid over ﬁ  tting, the number of variables 
included the classiﬁ  er was restricted to the a ﬁ  fth 
of the study sample (Draper and Smith 1981). The 
10,000 lists of candidate m/z values were examined 
and the most frequently occurring local maximums 
(AUCs) were included in the ﬁ  nal classiﬁ  er. The 
covariance matrices in the two groups were tested 
to see if they were signiﬁ  cantly different. If they 
were, a quadratic function (instead of linear) was 
used as a discriminating function. The ﬁ  rst two 
data sets were from pilot studies and had very small 
sample numbers. In this case, a “leave-one-out” 
cross-validation was used to assess the quality of 
the classiﬁ  er. This method randomly selects an 
individual, leaves him/her out of the sample, cal-
culates the discriminant function using the other 
individuals and then classiﬁ  es this “unknown” 
individual. Cross-validation is understood to yield 
a fairly unbiased estimate of the sensitivity and 
specificity of the classifier (Lachenbruch and 
Goldstein 1979). The third data set was large 
enough to allow one to separate the cases and 
controls into training and test data sets. In this case 
the quality of the classiﬁ  er was determined by the 
quality of classiﬁ  cation in the test set.
Data Sets Used
The ﬁ  rst pilot data set consisted of SELDI proﬁ  les 
of sera from twenty-one women with normal pap 
smears and twenty-one women with abnormal 
(HSIL) pap smears. The purpose of the study was 
to see if the spectra of the two groups were differ-
ent enough to enable one to separate the two 
groups out.
In the second data set body cavity ﬂ  uids were 
obtained from the University of Alabama at 
Birmingham. Twenty-two samples consisted of 
10 pleural fluids obtained by thoracocentesis, 
7 pelvic washings obtained during hysterectomy 
and/or oophorec-tomy, 4 peritoneal ﬂ  uids by para-
centesis, and 1 peri-cardial ﬂ  uid by pericardiocen-
tesis. The aim of the study was to determine whether 
protein proﬁ  les generated by SELDI-TOF MS could 
differentiate reactive/inﬂ  ammatory conditions from 
neoplastic disease.
Qu et al (2002) have described the third data 
set used in this study. Specimens from two groups 
of patients were used in this study: 80 age-matched 
controls and 80 patients diagnosed with 82
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organ-conﬁ  ned PC A (T1/T2). A donor was selected 
for the control group if he had a normal digital 
rectal examination (DRE), a prostate specific 
antigen (PSA) level of less than 4.0 ng/ml, and no 
evidence of prostatic disease. The control group 
consisted of 40 Caucasian and 40 African-
American males ranging in age from 51–70 years 
(mean age, 60 years). The organ-confined 
PCA group (T1/T2) consisted of 76 Caucasians, 
20 African Americans, 1 Asian, and 2 men of 
unknown race with ages ranging from 50–89 years 
(mean age, 71 years).
Results
Data Set 1: HSIL versus Normal
The first data set consisted of SELDI spectra 
obtained from the sera of 21 women with normal 
pap smears and of 21 women with HSIL. Figure 1a 
shows the averaged spectra in the Normal and 
HSIL. The spectra are fairly similar. In Figure 1b 
is a closer view of the spectra between 7200 m/z 
and 9600 m/z. Figure 1c displays the same region 
(7200m/z to 9600 m/z) of the original spectrum, 
and the aligned, smoothed spectrum. This ﬁ  gure 
suggests that the alignment and feature selection 
using maximums, works to reduce the dimension-
ality of the data to one tenth of the original data 
(10458 m/z values to 1074), but keeps the main 
characteristics of the original spectrum. Figure 2a 
represents the trace of the maximum intensities 
between 7000m/z and 10000m/z region of the 
spectrum. Figure 2b is the trace of the AUCs 
between 7000m/z and 10,000m/z. As one can see, 
the AUC trace also provided a fairly good summary 
of the original spectrum, although the magnitude 
of the AUCs are as expected much larger than the 
values of just the maximums at a particular m/z 
value. These ﬁ  ndings were repeated in the other 
two data sets used in the study.
Total Protein Content The total protein content 
in each sample was estimated by adding up all the 
protein intensities in an individuals’ spectrum. 
Wil-coxon’s rank sum test was used to see if the 
total protein content in the two groups were sig-
niﬁ  cantly different. In this data set total protein 
content in the two groups was not signiﬁ  cantly 
different (p = 0.77). Thirteen m/z values had 
maximums that were significantly different at 
p = 0.05.
The quadratic discriminant classiﬁ  er that used 
maximums had a cross-validated speciﬁ  city of 76% 
and sensitivity of 62%. Thirty-three AUCs were 
signiﬁ  cantly different at p = 0.05. The classiﬁ  er 
that used AUC instead of peaks had 100% speciﬁ  c-
ity and 67% sensitivity.
Data Set 2
This data set had SELDI spectra from the pleural 
ﬂ  uid of eight patients with various diagnoses of 
cancer and fourteen patients who had normal 
Figure 1a: Normalised mean spectra.
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pleural or peritoneal biopsies. The total protein 
content in the ﬂ  uid of the cancer group was sig-
niﬁ  cantly higher (p = 0.0044) than the protein 
content in the ﬂ  uid from the normal group. 84 m/z 
values had signiﬁ  cantly different maximum inten-
sities at p = 0.0002. The quadratic discriminant 
classiﬁ  er that used the local maximums had a cross-
validated speciﬁ  city = 100% and sensitivity = 
62.5%. 39 m/z values had signiﬁ  cantly different 
AUCs at p = 0.0002. The quadratic discriminant 
classiﬁ  er that used AUCs had a cross-validated 
speciﬁ  city = 100% and sensitivity = 100%.
Data Set 3
The third data set is one that has been extensively 
analyzed and discussed in the various publications 
(Qu et al 2002; Diamandis 2003; Yasui et al 2003).
We used SELDI spectra from 80 normal cases 
and 88 prostate cancer cases (stage a or b) obtained 
from the Microbiology and Molecular Cell Biology 
laboratory at the East Virginia Medical School. The 
total protein content in the two groups was sig-
niﬁ  cantly different (p  0.0001) but in this case it 
was higher in the normal cases, when compared to 
the cancer cases. For this analysis, we adapted the 
macro used previously to select subsets of cases 
and controls before the Wilcoxon rank sum test to 
identify maximums or AUCs that were signiﬁ  -
cantly different. Sixty-eight cases and sixty con-
trols were randomly selected to form the data set. 
The remaining twenty cases and twenty controls 
were set aside as the test set. Forty cases and con-
trols from each group were then selected from the 
training set, at each run to identify signiﬁ  cantly 
different intensities or AUCs. These values were 
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then subjected to SWD, and lists of potential m/zs 
were stored. The process in this case was replicated 
5000 times. The quadratic discriminant classiﬁ  er 
using local maximums had a test set speciﬁ  city of 
90% and sensitivity = 95%. The classiﬁ  er using 
the AUC fared a little worse, with speciﬁ  city = 90% 
and sensitivity = 85%. Both classiﬁ  ers had seven 
variables. Five of the seven m/z values identiﬁ  ed 
by the two techniques were identical.
Conclusion
The protocol described in this paper is unique in 
several ways. To the best of our knowledge, the 
technique used to align the m/z values has not been 
described elsewhere.
The method reduces the dimensionality of the 
data, while keeping its main characteristics, and 
we believe has the added advantage of being 
intuitive and thus easily replicated. We are also not 
aware of any other study that has compared the 
total protein content in the two groups being stud-
ied. The results here suggest that total protein 
content may be able to distinguish between cancer 
and non-cancer specimens; this is very important 
in that analysis without the correction for total 
protein will always separate cancer from non-
cancer in such a group. The biological bias and/or 
plausibility of these ﬁ  ndings are under evaluation 
in our laboratory. We are planning additional 
experiments to evaluate these issues. In this anal-
ysis, the maximum intensity or AUC at every set 
of differentiable m/z values is being tested for 
signiﬁ  cant differences. The advantage of AUC 
versus peak intensity, or the local maximum used 
in this study, is not yet clear. The results from the 
ﬁ  rst two studies seem to suggest that AUC may be 
more sensitive than using local maximums. 
However this conclusion was not conﬁ  rmed by the 
third study, which had a larger sample size and 
used a test data set for assessing accuracy of the 
classiﬁ  er.
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